Back to search

Peptide record

TPDB13610

Antibacterial Anticancer Toxicity standard
31 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB13610
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia
standard
No
A 31-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
RFRRLRWKTRWRLKKIRFGRFLRKIRRFRPK
Physicochemical Analysis
C201H334N74O33
ANDCEQHMSYV
R
4315.34
13.44
17
0
11
+17
4.75
-1.497
62.90
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
11000
254.90
1
Residue Composition
number
0
A
12
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
2
I
3
L
5
K
0
M
4
F
1
P
0
S
1
T
2
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 12 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 2 L: 3 K: 5 M: 0 F: 4 P: 1 S: 0 T: 1 W: 2 Y: 0 V: 0
Chemical Descriptors
31
C201H334N74O33
4315.34
13.44
+17
4.75
-1.497
Evidence Records 2 records
Evidence 1 Activity

Activity

15.44% Hemolysis
Toxicity
294.3 µg/mL
Hemolytic Cytotoxic
15.44% Hemolysis | 294.3 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Characterization of cell selectivity, physiological stability and endotoxin neutralization capabilities of ?-helix-based peptide amphiphiles. | Biomaterials | 2015
Evidence 2 Activity

Activity

% Hemolysis
Toxicity
0 %
Hemolytic Cytotoxic
Hemolytic_activity: [Ref.25818457] 0% hemolysis at 9.2 mg/L , 1% hemolysis at 18.4 mg/L , 4% hemolysis at 36.8mg/L , 5% hemolysis at 73.6 mg/L , 10% hemolysis at 147.1 mg/L , 13% hemolysis at 294.3 mg/L against human red blood cells | Cytotoxicity: [Ref.25818457] The cell viability of PR-FO is 93%, 89%, 84%, 79%, 74%, 69%, 67%, 64% and 62% at peptide concentrations of 1.1, 2.3, 4.6, 9.2, 18.4, 36.8, 73.6, 147.1 and 294.3 µg/ml.

Target

erythrocytes

Source & Reference

NA
DRAMP
Biomaterials. 2015 Jun 52:517-30. doi: 10.1016/j.biomaterials.2015.02.063.